I've got Eyes On the Review / Preview Articles for the Healthcare Industry. It's interesting to see a snapshot of 2022 and some predictions

After all the quarterly results reporting, we've had eyes on product approvals, resubmissions, and a withdrawal.

We've had Eyes On the Hema space - trying to keep up with the latest data and approvals for Hemophilia, Sickle Cell, and Beta Thalassemia ..

This week we were catching up on the news around the US Infant Formula Shortage and new cases filed against Zantac Manufacturers

This week we had Eyes On the acquisition of Forma Therapeutics by Novo Nordisk - a typically reticent player in the M&A arena.

This week PharmaTell had Eyes On: Heartburn – the kind caused by the upcoming Zantac litigation & resulting market jitters.